Targeted Immunotherapy for Staphylococcal Infections

作者: Michael Otto

DOI: 10.2165/00063030-200822010-00003

关键词:

摘要: Staphylococcal infections represent an enormous burden to the public health system in US and worldwide. While traditionally restricted hospital setting, highly virulent strains have recently emerged that may cause severe, even fatal, disease healthy adults outside healthcare settings. This situation, together with increasing resistance many antibacterials a wide variety of staphylococcal strains, requires vaccine development for diseases be re-evaluated. Finding staphylococci is not trivial, as protective immunity does appear exist at significant degree, which partly due fact our immune constant contact antigens are commensal organisms on human epithelia. Furthermore, most species, Staphylococcus aureus, produces protein A, powerful means evade acquired host defense. two high-profile preparations failed clinical trials within last few years, promising results from novel approaches based combination systematically selected been reported. These combinatory vaccines target microbial surface components recognizing adhesive matrix molecules (MSCRAMMs), family bacterial proteins bind extracellular components. In addition, polysaccharide other nonprotein suitable targets cell surface.

参考文章(69)
Joseph M Patti, Pietro Speziale, Jorge M Rivas, Magnus Höök, MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection. Current Opinion in Drug Discovery & Development. ,vol. 7, pp. 223- 227 ,(2004)
Kirk W. McCrea, Orla Hartford, Stacey Davis, Deirdre Nı́ Eidhin, Gerard Lina, Pietro Speziale, Timothy J. Foster, Magnus Höök, The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology. ,vol. 146, pp. 1535- 1546 ,(2000) , 10.1099/00221287-146-7-1535
Kelly C Rice, Ethan E Mann, Jennifer L Endres, Elizabeth C Weiss, James E Cassat, Mark S Smeltzer, Kenneth W Bayles, The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 8113- 8118 ,(2007) , 10.1073/PNAS.0610226104
Cuong Vuong, Michael Otto, Staphylococcus epidermidis infections Microbes and Infection. ,vol. 4, pp. 481- 489 ,(2002) , 10.1016/S1286-4579(02)01563-0
Stacey L. Davis, Sivashankarappa Gurusiddappa, Kirk W. McCrea, Samuel Perkins, Magnus Höök, SdrG, a Fibrinogen-binding Bacterial Adhesin of the Microbial Surface Components Recognizing Adhesive Matrix Molecules Subfamily from Staphylococcus epidermidis, Targets the Thrombin Cleavage Site in the Bβ Chain Journal of Biological Chemistry. ,vol. 276, pp. 27799- 27805 ,(2001) , 10.1074/JBC.M103873200
Marisa I Gómez, Aram Lee, Bharat Reddy, Amanda Muir, Grace Soong, Allyson Pitt, Ambrose Cheung, Alice Prince, Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 Nature Medicine. ,vol. 10, pp. 842- 848 ,(2004) , 10.1038/NM1079
Ignazio Castagliuolo, Renata Piccinini, Elisa Beggiao, Giorgio Palù, Carlo Mengoli, Federica Ditadi, Gaddo Vicenzoni, Alfonso Zecconi, Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice. Vaccine. ,vol. 24, pp. 4393- 4402 ,(2006) , 10.1016/J.VACCINE.2006.02.055
S PROJAN, M NESIN, P DUNMAN, Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Current Opinion in Pharmacology. ,vol. 6, pp. 473- 479 ,(2006) , 10.1016/J.COPH.2006.04.005
Timothy J Foster, Magnus Höök, Surface protein adhesins of Staphylococcus aureus Trends in Microbiology. ,vol. 6, pp. 484- 488 ,(1998) , 10.1016/S0966-842X(98)01400-0